A specialized subset of rare immune cells called plasmacytoid dendritic cells may promote antitumor immunity, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
A new potential drug target has been identified in SARS CoV-2 – the virus that causes COVID-19 – by scientists who say multiple drugs will likely be needed to respond to the pandemic.
Gold-plated nanocrystals could help rebuild nerves damaged by multiple sclerosis, according to a recent study.
A potential drug target has been identified in a newly mapped protein of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19).
A recent study has found that the gallbladder may play a crucial role in the transmission of a common infection found in hospital settings, according to findings published in Nature Communications.
Northwestern scientists have determined that a toxin secreted by Vibrio cholerae bacteria, the pathogen responsible for cholera, suppresses the body’s normal immune response.
Three Chicagoland high school students created the PeelTowel, a citrus peel-based, anti-microbial paper towel, and tested it in the laboratory of Alan Hauser, MD, PhD, vice chair of the Department of Microbiology-Immunology.
In a new clinical exposure program, doctoral students in the Driskill Graduate Program in Life Sciences partner with clinicians at Lurie Children’s Hospital to forge connections between basic and clinical research efforts.
A recent study has shed light on how different strains of bacteria compete to cause pneumonia, findings that could inform how to best prevent infection.
Northwestern investigators are exploring the potential of bacterial toxins to be turned into therapeutic agents to effectively ward off disease.